Venture financing for mRNA-based innovator vaccines saw an 82% decline from $510 million in 2023 to $90 million in 2025 ...

The nation's greatest struggles, from layoffs and Medicaid cuts to the fiery immigration debate, are playing out in rural ...

VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced the publication of the miniVec plasmid system, engineered for safer, more efficient, and more scalable ...

The biotech and pharma Industries are growing healthcare solutions for the future. These locations support the industry's ...

Wall Street’s broader market averages closed mixed on Friday as market participants digested the U.S. government shutdown for the third day. For the week, the Dow, S&P 500, and Nasdaq Composite ...

A research team led by Cancer Center at Illinois (CCIL) member Hua Wang has published new research detailing a new mRNA ...

Interferon lambda concentrations in nasal lining fluid fell in or above the predicted therapeutic range with a nasally ...

Our RNAi play came from the understanding that personalization and the development of curated therapies are the future of ...

Transcending transplants A condition that could formerly only be treated with a liver transplant can now be treated with medication. After 30 years of research, Dr. Jeffrey Teckman, a professor of ...

Amid growing use of artificial intelligence (AI) across the globe — along with several concerns about its future and ...

IMD’s AI Navigator helps leaders align business goals with AI models to capture value, manage risk, and move from hype to ...

What if you could squeeze, say, a 70% dividend yield from a fast-growing AI stock like NVIDIA (NVDA) or Palantir (PLTR)?